DK148890D0 - Farmaceutisk praeparat - Google Patents

Farmaceutisk praeparat

Info

Publication number
DK148890D0
DK148890D0 DK148890A DK148890A DK148890D0 DK 148890 D0 DK148890 D0 DK 148890D0 DK 148890 A DK148890 A DK 148890A DK 148890 A DK148890 A DK 148890A DK 148890 D0 DK148890 D0 DK 148890D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
epi
increase
mucopolysaccharide
prophylaxis
Prior art date
Application number
DK148890A
Other languages
Danish (da)
English (en)
Inventor
Ole Juul Nordfang
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK148890A priority Critical patent/DK148890D0/da
Publication of DK148890D0 publication Critical patent/DK148890D0/da
Priority to AT91912208T priority patent/ATE119781T1/de
Priority to DE69108242T priority patent/DE69108242T2/de
Priority to AU80604/91A priority patent/AU645581B2/en
Priority to CA002085101A priority patent/CA2085101A1/en
Priority to HU9204036A priority patent/HU221323B1/hu
Priority to DK91912208.5T priority patent/DK0535129T3/da
Priority to PCT/DK1991/000145 priority patent/WO1991019514A1/en
Priority to JP51133391A priority patent/JP3362038B2/ja
Priority to ES91912208T priority patent/ES2069894T3/es
Priority to EP91912208A priority patent/EP0535129B1/en
Priority to BG97199A priority patent/BG61181B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DK148890A 1990-06-19 1990-06-19 Farmaceutisk praeparat DK148890D0 (da)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat
EP91912208A EP0535129B1 (en) 1990-06-19 1991-05-30 An anticoagulant preparation
CA002085101A CA2085101A1 (en) 1990-06-19 1991-05-30 An anticoagulant preparation
DE69108242T DE69108242T2 (de) 1990-06-19 1991-05-30 Antikoagulanszubereitung.
AU80604/91A AU645581B2 (en) 1990-06-19 1991-05-30 An anticoagulant preparation
AT91912208T ATE119781T1 (de) 1990-06-19 1991-05-30 Antikoagulanszubereitung.
HU9204036A HU221323B1 (en) 1990-06-19 1991-05-30 Synergetic anti-coagulant preparatives containing epi protein and mucopolysaccharide and process for producing them
DK91912208.5T DK0535129T3 (da) 1990-06-19 1991-05-30 Et antikoagulerende præparat
PCT/DK1991/000145 WO1991019514A1 (en) 1990-06-19 1991-05-30 An anticoagulant preparation
JP51133391A JP3362038B2 (ja) 1990-06-19 1991-05-30 抗凝血剤
ES91912208T ES2069894T3 (es) 1990-06-19 1991-05-30 Una preparacion anticoagulante.
BG97199A BG61181B1 (bg) 1990-06-19 1992-12-18 Антикоагулантен препарат

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
DK148890D0 true DK148890D0 (da) 1990-06-19

Family

ID=8105367

Family Applications (2)

Application Number Title Priority Date Filing Date
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat
DK91912208.5T DK0535129T3 (da) 1990-06-19 1991-05-30 Et antikoagulerende præparat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91912208.5T DK0535129T3 (da) 1990-06-19 1991-05-30 Et antikoagulerende præparat

Country Status (11)

Country Link
EP (1) EP0535129B1 (es)
JP (1) JP3362038B2 (es)
AT (1) ATE119781T1 (es)
AU (1) AU645581B2 (es)
BG (1) BG61181B1 (es)
CA (1) CA2085101A1 (es)
DE (1) DE69108242T2 (es)
DK (2) DK148890D0 (es)
ES (1) ES2069894T3 (es)
HU (1) HU221323B1 (es)
WO (1) WO1991019514A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849703A (en) * 1990-08-27 1998-12-15 G. D. Searle & Co. Pre-formed anticoagulant heparin/TFPI complexes
US6291427B1 (en) 1990-08-27 2001-09-18 G.D. Searle & Co. Anticoagulant combination of LACI and sulfated polysaccharides
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
KR950701820A (ko) * 1992-06-11 1995-05-17 로저 에이. 윌리암스 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
ZA941414B (en) * 1993-03-02 1994-09-28 Novo Nordisk A G Non-glycosylated TFPI analogues
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
PL374506A1 (en) 2001-10-15 2005-10-31 Chiron Corporation Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048898B1 (en) * 1980-09-30 1985-04-17 Bayer Ag Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
US4900723A (en) * 1988-04-29 1990-02-13 E. R. Squibb & Sons, Inc. Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner

Also Published As

Publication number Publication date
JPH05507926A (ja) 1993-11-11
BG61181B1 (bg) 1997-02-28
DE69108242D1 (de) 1995-04-20
HU221323B1 (en) 2002-09-28
EP0535129B1 (en) 1995-03-15
HUT63578A (en) 1993-09-28
AU645581B2 (en) 1994-01-20
AU8060491A (en) 1992-01-07
ES2069894T3 (es) 1995-05-16
ATE119781T1 (de) 1995-04-15
EP0535129A1 (en) 1993-04-07
HU9204036D0 (en) 1993-03-29
WO1991019514A1 (en) 1991-12-26
DK0535129T3 (da) 1995-08-07
DE69108242T2 (de) 1995-07-06
CA2085101A1 (en) 1991-12-20
JP3362038B2 (ja) 2003-01-07

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
HU9300636D0 (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ES2119411T5 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
DK148890D0 (da) Farmaceutisk praeparat
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
ES2055902T3 (es) Composiciones farmaceuticas de proteinas activadoras del plasminogeno.
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
FI913625A0 (fi) Behandling av nedsatt funktion av leukocyter med gm-csf.
AU2001261987A1 (en) Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
KR910005858A (ko) 지방산 요법
DK0651654T3 (da) Anvendelse af lysozymdimer til fremstilling af et lægemiddel til styrkelse af de naturlige forsvarsmekanismer
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
RU92016457A (ru) Антикоагулирующий препарат
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
Balas et al. Venous Thrombosis in Childhood
DK0788355T3 (da) Anvendelse af intravenøst indgiveligt jern til behandling af tumorsygdomme og/eller infektionssygdomme
UA30723A (uk) Спосіб лікування аутоімунних захворювань

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment